CMC CHESTERFIELD LIMITED

Financial Health Score: C+ (Stable but Vulnerable)

This grade reflects a business that has successfully pulled itself out of the emergency room but remains in a fragile state of recovery. CMC Chesterfield Limited has managed to reverse a history of balance sheet insolvency, returning to positive net assets and maintaining profitability. However, for a company generating nearly £29 million in turnover, its profit margins are alarmingly thin, and its historical reliance on debt leaves it vulnerable to economic shocks.

1. Key Vital Signs

Pulse (Revenue): Turnover stands at £28.9 million (down from £31.9 million in 2023). While still a healthy top-line figure representing strong market demand, the 9.4% drop in revenue is a mild arrhythmia, indicating that the "cost of living" pressures and rising interest rates are suppressing consumer demand for motorcycles and accessories.

Blood Pressure (Profitability): Pre-tax profit is £412,556 (down from £1.05m in 2023). The gross profit margin actually improved slightly to 19.4% (up from 18.5%), which is a positive vital sign that inventory pricing and product mix are being managed well. However, the net profit margin is roughly 1.4%. For a business of this size, the pulse is present but very weak—there is very little margin for error if costs rise or sales dip further.

Immune System (Net Assets & Equity): Historically, this patient was very sick. From 2019 to 2021, the company suffered from negative shareholders' funds (accumulated losses), meaning its liabilities exceeded its assets—a condition akin to a severely compromised immune system. In 2022, the company turned a corner, reporting positive net assets of £280k. By the end of 2024, net current assets (working capital) have improved to £883,124. The patient is building antibodies, but the overall equity cushion for a £29m business remains dangerously thin.

Hydration (Cash & Liquidity): Historical cash positions were perilously low (just £8,362 in 2022 and £8,505 in 2020). While specific 2024 cash figures aren't in the extracted history, the strong net current asset position suggests liquidity has improved. The company has confirmed it can operate within its banking covenants, meaning the cash flow "hydration" is currently sufficient to keep the organs functioning, but it must be monitored closely.

2. Symptoms Analysis

The Chronic Condition (Historical Insolvency): For years, the company operated with negative net assets. This means the business was technically insolvent on its balance sheet, surviving only through the grace of its creditors and stakeholders. This chronic condition leaves a scar: the equity buffer remains very small relative to the company's size and debt load.

The Current Treatment (Debt & Stakeholder Support): The company has high financial leverage (total liabilities of £9.8m against total assets of £10.2m in 2022). The directors explicitly note that the going concern basis is dependent on the "ongoing key stakeholders of their continued support at the required levels." This is a symptom of a business still reliant on external life support—be that bank financing or creditor patience.

Market Flu (Macro Headwinds): The strategic report highlights fragile consumer confidence and rising interest rates. These macroeconomic viruses are directly impacting the business, causing reduced demand and market-wide inventory gluts that threaten margin compression.

3. Diagnosis

Recovering from Critical Illness, But Still in the High-Risk Ward

CMC Chesterfield Limited is a classic example of a high-turnover, low-margin retail business that has navigated a severe balance sheet crisis. The transition from negative net assets of over £2.3 million in 2020 to positive net assets and consistent profitability is a testament to strong operational discipline and cost control.

However, the financial anatomy is still heavily leveraged. With total liabilities nipping at the heels of total assets, the business lacks a robust financial cushion. A sudden shock—such as a further tightening of consumer spending or an unexpected rise in borrowing costs—could easily push the patient back into distress. The drop in pre-tax profit from £1.05m to £0.41m, despite an improvement in gross margin, suggests that overheads and financing costs are taking a heavier toll on the bottom line.

4. Recommendations

To improve its financial wellness and graduate from the high-risk ward to a state of robust health, CMC Chesterfield Limited should consider the following treatment plan:

1. Build an Equity Buffer (Rehabilitation): The priority must be retaining profits to rebuild retained earnings. Do not pay dividends. Every pound of profit should be retained to strengthen the balance sheet and reverse the historical accumulated losses, building a thicker skin against future market shocks.
2. Debt Reduction Therapy (Lowering Blood Pressure): With high liabilities and rising interest rates, the cost of debt is a major drag on profitability. Prioritize paying down high-interest borrowings to reduce finance costs, which will instantly improve the net profit margin.
3. Working Capital Management (Diet and Exercise): The strategic report mentions an increase in available inventory throughout the market. Ensure stock levels are tightly managed. Excess inventory ties up cash and requires discounting to clear, both of which harm financial fitness.
4. Scenario Planning (Preventative Medicine): Given the reliance on stakeholder support for going concern viability, the business should stress-test its cash flows against various negative scenarios (e.g., a 15% drop in sales, a 2% rise in interest rates) to ensure it can maintain banking covenants without requiring emergency capital injections.